Ischemic Mitral Regurgitation

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

L
LabcorpNC - Burlington
1 program
Implant an epicardial device to reshape the mitral valve annulusN/A1 trial
Active Trials
NCT04396379Not Yet Recruiting10Est. Dec 2027

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
2027
LabcorpImplant an epicardial device to reshape the mitral valve annulus

Clinical Trials (1)

Total enrollment: 10 patients across 1 trials

NCT04396379LabcorpImplant an epicardial device to reshape the mitral valve annulus

Epicardial Mitral Touch System for Mitral Insufficiency

Start: Sep 2023Est. completion: Dec 202710 patients
N/ANot Yet Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space